News
FDA grants orphan drug and fast-track designation to RLS-0071 for aGVHD
The FDA has granted orphan drug designation and fast track designation to RLS-0071 (ReAlta Life Sciences Inc) for the treatment
4 Minute
September 20, 2024
The FDA has granted orphan drug designation and fast track designation to RLS-0071 (ReAlta Life Sciences Inc) for the treatment